CWA Asset Management Group’s ResMed RMD Stock Holding History

CWA Asset Management Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+1,124	New	+$233K	0.01%	653
2022 Q3	–	Sell	-3,457	Closed	-$725K	–	323
2022 Q2	$725K	Sell	3,457 -22,284	-87%	-$4.74M	0.07%	143
2022 Q1	$6.24M	Hold	25,741	–	–	0.48%	59
2021 Q4	$6.71M	Sell	25,741 -66	-0.3%	-$17.1K	0.5%	52
2021 Q3	$6.8M	Sell	25,807 -447	-2%	-$122K	0.54%	52
2021 Q2	$6.51M	Buy	26,254 +2,251	+9%	+$473K	0.53%	54
2021 Q1	$4.66M	Buy	+24,003	New	+$4.81M	0.43%	70

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CWA Asset Management Group's RMD Position: Q2 2026 in Review

CWA Asset Management Group opened a new position in ResMed (RMD) in Q2 2026: 1,124 shares worth $219K. The stake represents 0.01% of the portfolio and ranks #653 among its holdings. This is a return to the name: CWA Asset Management Group previously reported a position in RMD as recently as Q2 2022.

CWA Asset Management Group first reported a position in RMD in Q1 2021 and has held it in 7 quarters since. The position peaked at $6.8M in Q3 2021. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

CWA Asset Management Group held 1,124 shares of ResMed worth $219K as of Q2 2026.
ResMed was a new CWA Asset Management Group position in Q2 2026.
ResMed made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #653 holding.
CWA Asset Management Group first reported a position in ResMed in Q1 2021 and has held it in 7 quarters since.
CWA Asset Management Group's ResMed position peaked at $6.8M in Q3 2021.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.